Saturday links: clean hands
Tadas Viskanta
Abnormal Returns
1 week ago
3 MIN READ
Tesla
- Tesla ($TSLA) has a China problem. (advisorperspectives.com)
- Tesla ($TSLA) FSD has a sun glare problem. (bloomberg.com)
- Elon Musk has buyer’s remorse. (sherwood.news)
Autos
- Waymo is increasing its lead in self-driving vehicles. (wsj.com)
- Slate EVs are ambitious price-wise. (sherwood.news)
- Why Nepal loves EVs. (fastcompany.com)
Energy
- In the South, solar power pays better than timber. (wsj.com)
- The administration is preventing this Michigan coal plan from closing, despite everyone’s desire to shut it down. (msn.com)
- Everybody loves geothermal, but will tax credits survive the budget process? (wsj.com)
- On the pros and cons of floating solar panels. (arstechnica.com)
Environment
- “A hotter world is a thirstier one” or why droughts are likely to worsen. (nytimes.com)
- Wildfire smoke is now a fixture of Summer in the northern U.S. (vox.com)
- Western North Carolina didn’t turn out to be a climate refuge. (npr.org)
- How doppler radar works. (scientificamerican.com)
Travel
- Capital One ($COF) is cutting back cardmember access to its lounges. (nerdwallet.com)
- Foreign tourists are increasingly bypassing the U.S. this summer. (wsj.com)
- Should you travel with a carbon monoxide monitor? (wsj.com)
AI
- OpenAI wants to be the world’s AI company. (sherwood.news)
- How regulating AI could backfire. (agglomerations.substack.com)
- AI is coming for ads. (semafor.com)
Science
- The race is on to recruit American scientists to countries more favorable to research. (nytimes.com)
- On the downstream impacts of crushing science. (axios.com)
Medicine
- Immigration policy means the doctor shortage in the U.S. is going to get worse. (statnews.com)
- A natural experiment in what happens when you reduce the amount of doctors. (klementoninvesting.substack.com)
MAHA
- A look at where NIH cuts have occurred. (nytimes.com)
- Moderna ($MRNA) is a loser in the MAHA movement. (wsj.com)
- Everybody talks their book, especially wellness influencers. (apnews.com)
Health
- Huge news. An actual treatment for multiple myeloma. (nytimes.com)
- A twice-year shot to prevent HIV is likely coming to market. (wsj.com)
- The case for Covid boosters during pregnancy. (npr.org)
- Research that shows exercise can help cancer patients. (statnews.com)
Food
- Some new niche food delivery startups are gaining ground. (cnbc.com)
- On the link between coffee consumption and health. (cnn.com)
- Eat more fiber! (newatlas.com)
Sports
- Cancelling ‘Around the Horn’ seems like an own-goal for ESPN. (spyglass.org)
- There limited treatment options for gambling addiction. (theatlantic.com)
- The tough math of being a professional tennis player. (papers.ssrn.com)
Children
- It’s hard to know what future you are preparing your children for. (contessacapitaladvisors.com)
- What happens when parents don’t read to their children. (theguardian.com)
Earlier on Abnormal Returns
- What you missed in our Friday linkfest. (abnormalreturns.com)
- Podcast links: smartphone research. (abnormalreturns.com)
- Don’t miss a thing! Sign up for our daily e-mail newsletter. (abnormalreturns.com)
Mixed media
Terms and Conditions
This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.
The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.
References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.
Please see disclosures here.
